Company: RITM-PC
Filing Date: 2025-08-01
Form Type: 424B5
Source: 0001140361-25-028380
Chunk: 12

Company: Rithm Capital Corp.
Filing Date: 2025-08-01
Form: 424B5
Chunk 12
---
 Delaware corporation.

#### Common Stock Offered
Common stock, $0.01 par value per share, having aggregate sales proceeds of up to $500,000,000. Of that amount, we have sold shares of our common stock having an aggregate offering price of $196,208,193 as of the date of this prospectus supplement, pursuant to the Distribution Agreement, a registration statement on Form S-3 (File No. 333-266599) filed on August 5, 2022 and a prospectus supplement dated August 5, 2022. Accordingly, as of the date of this prospectus supplement, shares of our common stock having an aggregate offering price of $303,791,807 remain available for offer and sale pursuant to the Distribution Agreement and this prospectus supplement.

#### Common Stock Outstanding Prior to this Offering
530,292,171 shares of common stock, as of July 29, 2025.

#### Manner of Offering
“At the market offering” that may be made from time to time through our sales agents, BofA Securities, Inc., Barclays Capital Inc., BTIG, LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Nomura Securities International, Inc., Raymond James & Associates, Inc., RBC Capital Markets, LLC and Wells Fargo Securities, LLC. See “Plan of Distribution.”

Under the terms of the Distribution Agreement, we also may sell shares to the sales agent, as principal for its own account, at a price per share to be agreed upon at the time of sale. If we sell shares to any sales agent, acting as principal, we will enter into a separate terms agreement with that sales agent, setting forth the terms of such transaction, and we will describe the terms agreement in a separate prospectus supplement or pricing supplement.

The proceeds from this offering, if any, will vary depending on the number of shares that we offer and the offering price per share. We may choose to raise less than the maximum $500,000,000 in gross offering proceeds permitted by this prospectus supplement.

#### Use of Proceeds
We presently intend to use the net proceeds from any sales of shares of common stock resulting from this prospectus supplement for general corporate purposes, which may include, without limitation, future acquisitions, investments or repayment of indebtedness. See “Use of Proceeds.”

#### Risk Factors
Before deciding to invest in shares of our common stock, you should read carefully the risks set forth under the heading “Risk factors” beginning on page S